The groundwork for the development of novel tumor therapies that may help rid the body of cancer by inhibiting the recruitment of a specific suppressive immune cell type called "regulatory T-cells" has been laid by scientists. Their report is published in the Journal of Leukocyte Biology. The approach described in the report shows that an immune molecule, called interleukin-27, promotes the recruitment of regulatory T-cells. This suggests that by stopping IL-27's ...
Read More
You have just read an article categorized health
titled Endogenous Dendritic Cell-derived Interleukin-27 Might Promote Tumor Growth.
Written by:
editor -
Friday, May 2, 2014
There are currently no comments for "Endogenous Dendritic Cell-derived Interleukin-27 Might Promote Tumor Growth"
Post a Comment